Of Marfan's syndrome, mice, and medications

New England Journal of Medicine

Volumn 371, Issue 22, 2014, Pages 2127-2128

  Bowen, Juan M ^a   Connolly, Heidi M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; FIBRILLIN 1; LOSARTAN; TRANSFORMING GROWTH FACTOR BETA; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGE; AORTA DISSECTION; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EDITORIAL; GENE MUTATION; HEART PROTECTION; HUMAN; LIFE EXPECTANCY; MARFAN SYNDROME; MOUSE; NONHUMAN; PATHOGENESIS; AORTA; AORTIC ANEURYSM; DRUG EFFECTS; FEMALE; MALE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; AORTA; AORTIC ANEURYSM; ATENOLOL; FEMALE; HUMANS; LOSARTAN; MALE; MARFAN SYNDROME;

EID: 84915757706     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1412950     Document Type: Editorial

References (8)

1. Pyeritz RE. Marfan syndrome: 30 years of research equals 30 years of additional life expectancy. Heart 2009;95:173-5.
2. Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991;352:337-9.
3. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006;312:117-21.
4. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC III. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 2008;358:2787-95.
5. Chiu HH, Wu MH, Wang JK, et al. Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study. Mayo Clin Proc 2013;88: 271-6.
6. Groenink M, den Hartog AW, Franken R, et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J 2013;34:3491-500.
7. Lacro RV, Dietz HC, Sleeper LA, et al. Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med. DOI: 10.1056/NEJMoa1404731.
8. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994;330:1335-41.